In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 39 for your search:
Drug:  fluorine F 18 fluorothymidine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: P020907, NCT00236275

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OSI3926g, ML20773, NCT00453362

3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000573917, NCCTG-N057K, N057K, NCT00553150

4.

Phase: Phase II, Phase I
Type: Diagnostic
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 9420-04, 2004-033, NCT00624728

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 90
Sponsor: Other
Protocol IDs: J08101, CA180123, NCT00882583

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01438, 03-032, NCI-5917, CDR0000304738, MSKCC-03032, 5917, NCT00062374

7.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-005393-73, 06159, NCT00568841

8.

Phase: Phase II
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 200801758, 1R21CA130281, NCT00721799

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Completed
Age: 35 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: 0000-139, 2009_692, NCT01015131

10.

Phase: Phase II
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02899, NA_00017885, 8340, N01CM00070, P30CA006973, NCT00963807

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02012, CDR0000665163, RTOG-0837, U10CA021661, RTOG-0837-ACRIN-6689, NCT01062425

12.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 200906786, NCT01075412

13.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 10852, NCT01174238

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA191-011, NCT01225172

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: J0977, NA_00029263, NCT01226979

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00266, HM11081, CDR0000689109, ACRIN 6688, 8029, N01CM27165, NCT00572728

17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00245, CDR0000552705, H-2007-0039, CO06902, 7898, P30CA014520, U01CA062491, WCCC-CO-06902, NCT00499135

18.

Phase: Phase I
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: D0008186, NCT00553748

19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MC0622, 06-003532, MAYO-MC0622, NCT00575393

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 089025, NCT00859118

21.

Phase: Phase I
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2009-0658, NCT01143779

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00764, CDR0000688559, WCCC-CO-09904, 8477, CO 09904, P30CA014520, U01CA070095, U01CA062491, NCT01243359

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CO10907, NCT01540526

24.

Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000455011, UW-6230, NCI-7223, 6230, 7223, NCT00276770

25.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: FLT01 - UC-0140/0505, FRE-FNCLCC-FLT-01/0505, EU-20754, 2005-005166-37, FLT 01/0505, NCT00534274
1   
New Search